Stephen G. Machatha
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Stephen G. Machatha
The proxy statement of Aldeyra Therapeutics, Inc. reports total compensation of $1,452,142 for Stephen G. Machatha in fiscal 2025, including a base salary of $400,000. Disclosed compensation is on record for 5 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Aldeyra Therapeutics, Inc. (ALDX)
Proxy statement
Start not stated–2025-12-23
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Aldeyra Therapeutics, Inc. (ALDX) | Ph.D. . Chief Development Officer | $400,000 | $1,452,142 |
| 2024 | Aldeyra Therapeutics, Inc. (ALDX) | Ph.D. . Chief Development Officer | $392,340 | $1,688,381 |
| 2023 | Aldeyra Therapeutics, Inc. (ALDX) | Chief Development Officer | $377,250 | $1,593,108 |
| 2022 | Aldeyra Therapeutics, Inc. (ALDX) | Chief Development Officer | $359,287 | $2,565,216 |
| 2021 | Aldeyra Therapeutics, Inc. (ALDX) | Chief Development Officer | $333,572 | $1,431,416 |
Recent activity
No call appearances or filed executive changes recorded yet.